期刊文献+

甲型H1N1病毒HA、NA氨基酸序列比较及抗原性表位预测 被引量:1

Comparison of HA,NA Amino Acid Sequences of Novel Influenza Virus A/H1N1 and Prediction of Antigenic Epitopes
下载PDF
导出
摘要 目的:比较新型甲型H1N1流感病毒分离株HA、NA氨基酸序列之间的差异,分析HA、NA蛋白可能的抗原性细胞表位。方法:从GenBank中选取28株世界各地的新型甲型H1N1流感病毒分离株并下载各株HA、NA的氨基酸序列;使用ClustalX和MEGA2.0软件对氨基酸序列的进行进化树分析;用Protean软件预测HA、NA蛋白的B细胞表位;用NetMHCⅡ2.2预测T细胞抗原表位。结果:世界范围的毒株之间氨基酸序列相对保守,HA及NA均只有少数位点的变异,HA蛋白氨基酸序列之间较NA蛋白氨基酸序列之间变异较大;预测HA蛋白具有8个B细胞表位和10个T细胞表位;NA蛋白有12个B细胞表位和7个T细胞表位。结论:HA、NA蛋白的少数区域抗原性相对比较稳定,可以作为检测以及疫苗研究的靶区域。 Objective:To compare the amino acid sequences difference of HA,NA novel influenza virus A/H1N1 isolates,and decipher possible B cell epitopes and T cell epitopes of HA,NA protein.Method:The amino acid sequences of 28 novel influenza A/H1N1 virus isolates around the world were downloaded from Genbank. Phylogenetic trees were constructed based on the amino acid sequences of HA and NA by using software Clustal X and MEGA 2.0.B cell and T cell epitopes were respectively predicted with Protean software and NetMHC Ⅱ 2.2 online server.Result:HA protein sequences showed a relatively larger variation comparing to NA protein sequences,nevertheless both of them each had very less divergent amino acid residues. Software predictions revealed the presence of 8 B cell epitopes and 10 T cell epitopes randomly distributed throughout HA sequence and 12 B cell epitopes and 7 T cell epitopes throughout NA sequence. Conclusion:The antigenicity of HA,NA protein is relatively stable in certain regions which can be used as the target area in diagnosis and vaccine research.
出处 《中国医学创新》 CAS 2013年第19期1-3,共3页 Medical Innovation of China
基金 国家自然基金(编号:30771240)
关键词 H1N1流感病毒 抗原表位 血凝素 神经氨酸酶 Influenza virus A/H1N1 Antigenic epitope Hemagglutinin Neuraminidase
  • 相关文献

参考文献11

  • 1Centers for Disease Control and Prevention.Update:swine influenza A(H1N1)infections-California and Texas,April2009[J].MMWR Morb Mortal Wkly Rep,2009,58(16):435-437.
  • 2Centers for Disease Control and Prevention.Update:novel influenza A(H1N1)virus infection-Mexico,March-May,2009[J].MMWR Morb Mortal Wkly Rep,2009,58(21):585-589.
  • 3Zimmer S M and D S Burke.Historical perspective-Emergence of influenza A(H1N1)viruses[J].N Engl J Med,2009,361(3):279-285.
  • 4Hajjar L A,Schout D,Galas F R,et al.Guidelines on management of human infection with the novel virus influenza A(H1N1)-a report from the Hospital das Clinicas of the University of Sao Paulo[J].Clinics(Sao Paulo),2009,64(10):1015-1024.
  • 5Machala M K and L B Brydak.Various sides of influenza,part I-structure,replication,changeability of influenza viruses,clinical course of the disease,immunological response and laboratory diagnostics[J].Pol Merkur Lekarski,2006,21(123):270-276.
  • 6Su C Y,Wang S Y,Shie J J,et al.In vitro evaluation of neuraminidase inhibitorsusingtheneuraminidase-dependentreleaseassayofhemagglutinin-pseudotypedviruses[J].AntiviralRes,2008,79(3):199-205.
  • 7Kyte J and Doolittle R F.A simple method for displaying the hydropathic character of a protein[J].J Mol Biol,1982,157(1):105-132.
  • 8Karplus P A and Schulz G E.Substrate binding and catalysis by glutathione reductase as derived from refined enzyme:substrate crystal structures at2A resolution[J].J Mol Biol,1989,210(1):163-180.
  • 9Jameson B A and Wolf H.The antigenic index:a novel algorithm for predicting antigenic determinants[J].Comput Appl Biosci,1988,4(1):181-186.
  • 10Nicholson K G,Wood J M,Zambon M.Influenza[J].Lancet,2003,362(9397):1733-1745.

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部